Position in JNJ
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$174,869,011
+$15,658,151 QoQ
Shares Held
688,542
+5.7% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#220
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fayez Sarofim & Co holds $1,793,961,393 across 10 Drug Manufacturers - General names. JNJ ranks #4 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
2,876,785 | $723,914,175 | |
| 2 | LLY |
ELI LILLY & Co
|
425,688 | $510,582,998 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,664,909 | $213,940,806 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
688,542 | $174,869,011 | |
| 5 | NVO |
Novo Nordisk A S
|
2,924,500 | $140,200,529 | |
| 6 | AMGN |
Amgen Inc
|
54,394 | $19,697,155 | |
| 7 | PFE |
Pfizer Inc
|
233,339 | $5,618,802 | |
| 8 | NVS |
Novartis AG
|
28,162 | $4,413,548 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $174,869,011 | 688,542 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $159,210,860 | 651,329 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $136,391,639 | 659,056 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $155,192,830 | 836,980 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $128,736,325 | 842,791 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $145,721,285 | 878,686 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $130,662,722 | 903,490 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $146,350,713 | 903,065 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $132,544,318 | 906,844 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $154,218,797 | 974,896 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $162,735,931 | 1,038,254 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $201,759,795 | 1,295,408 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $281,740,362 | 1,702,153 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $315,621,540 | 2,036,268 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $421,214,504 | 2,384,458 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $393,347,191 | 2,407,855 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $426,986,456 | 2,405,422 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $399,298,301 | 2,252,995 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $362,028,766 | 2,116,261 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $331,898,650 | 2,055,100 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $340,047,245 | 2,064,145 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $341,540,170 | 2,078,127 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $330,447,480 | 2,099,679 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $315,228,833 | 2,117,335 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $299,101,022 | 2,126,865 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $258,729,060 | 1,973,073 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||